Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Pharmaceutical Biotechnology : Recent Progress and Future Applications / / edited by Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das
| Advances in Pharmaceutical Biotechnology : Recent Progress and Future Applications / / edited by Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (xviii, 478 pages) ; 92 illustrations, 56 illustrations in colour |
| Disciplina | 615.19 |
| Soggetto topico |
Pharmaceutical technology
Biomedical engineering Pharmacotherapy Biotechnology Drug resistance Biochemistry Biotecnologia farmacèutica Quimioteràpia Pharmaceutical Sciences/Technology Biomedical Engineering/Biotechnology Drug Resistance Biochemistry, general |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-2195-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1. Traditional And Ethnomedicine -- 1.Traditional Folk Medicine And Drug Discovery: Prospects And Outcome -- 2.Ethnomedicine For Drug Discovery -- 3.Medicinal And Aromatic Plants: Store House To Herbal Antimicrobials -- 4.Ethnomedicinal Plants Of North-East India As A Potential Target For Drug Discovery Against Type 2 Diabetes Mellitus -- 5.Application Of Phytochemicals In Pharmaceuticals -- 6.The Herbal Drugs -- 7.Role Of Natural Products As Alternative Of Synthetic Steroidal Drugs -- 8.Phytochemicals As Therapeutics In Heavy Metal Toxicity -- 9.Phytotherapies For Thyroidism: An Overview -- 10.Phytochemicals As Antidepressants -- 11.Phytochemistry And Medicinal Vaule Of Putranjiva Roxburghii Wall -- 12.Traditional Herbal Practices Of Eastern Ghats, Odisha, India For Treatment Of Bone Fracture -- 13.Screening Of Certain Medicinal Plants Of Manipur For Its Antifungal Activity Against Candida Species -- 14.Phytochemicals And Pharmaceutical: Overview -- 15.Millettia Pachycarpa Benth, A Herbal Medicinal Plant Of Southeast Asia -- 16.Phytochemicals And Their Role In Pharmaceuticals -- Section 2. Drug Discovery, Pharmaceutical Sciences And Future Medicine -- 17.Plant- Mediated Green Synthesis Of Nanoparticles -- 18.Biomedical Applications Of Green Synthesized Nanoparticles -- 19.Role Of Nanoparticles And Nanomaterials In Drug Delivery: An Overview -- 20.Micelleplexes: A Promising Nanocarriers For The Transport Of Genetic Material And Drugs -- 21.Phytomedicines And Their Prospects In Treatment Of Common Skin Diseases -- 22.Microbes As Natural Products For Drug Discovery -- 23.Natural Products From Actinobacteria For Drug Discovery -- 24.Anti – Leprosy Vaccine (Hansen’s Disease Vaccine) -- 25.Exploitation Of Fibrinolytic Enzymes In Combating Blood Clotting Disorders - Recent Advances And Strategies: A Comprehensive Review -- 26.Recent Development In Chronic Inflammation Research And Mangroves As Potential Source Of Anti-Inflammatory Agents -- Section 3. Clinical Trials And Ipr In Pharmaceuticals -- 27.Tissue Engineering And Regenerative Medicines: An Interdisciplinary Understanding -- 28.Ipr: An Overview -- 29.Intellectual Property Rights And Its Role In Natural Product Research -- 30.Nanotechnology In Preclinical Pharmacokinetics. |
| Record Nr. | UNINA-9910733708703321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Disordered pharmaceutical materials / / edited by Marc Descamps
| Disordered pharmaceutical materials / / edited by Marc Descamps |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Company KGaA, , [2016] |
| Descrizione fisica | 1 online resource (646 p.) |
| Soggetto topico |
Materials biomèdics
Biotecnologia farmacèutica Pharmaceutical biotechnology Biomedical materials |
| ISBN |
3-527-65269-8
3-527-65272-8 3-527-65271-X 9783527652693 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title Page; Copyright; Table of Contents; List of Contributors; Chapter 1: Some Facets of Molecular Disorder in Crystalline and Amorphous Pharmaceuticals; 1.1 The Crystal/Amorph Alternative; 1.2 Characteristics of the Disorder in Glass Formers; Acknowledgments; References; Chapter 2: Influence of Disorder on Dissolution; 2.1 Introduction; 2.2 Approaches to Enhance Solubility; 2.3 Measuring the Solubility Advantage of Amorphous Compounds; 2.4 Solid Dispersions; 2.5 Polymer Properties; 2.6 Drug-Polymer Interactions; 2.7 Polymer Concentration; 2.8 Other Formulation Components
2.9 Formulation Variables2.10 Reliable Measurement of Supersaturation; 2.11 Conclusion; References; Chapter 3: Crystal Imperfections in Molecular Crystals: Physical and Chemical Consequences; 3.1 Introduction; 3.2 General Aspects of Defects in Crystals; 3.3 Role of Imperfections in Reactivity and Stability - Chemistry in the Perfect and Imperfect Lattice; 3.4 Role in Physical Processes; 3.5 Concluding Remarks; References; Chapter 4: Observation and Characterization of Crystal Defects in Pharmaceutical Solids; 4.1 Introduction; 4.2 Techniques for Characterizing Defects within Crystals 4.3 Techniques for Characterizing Defects Emergent at Crystal Surfaces4.4 Techniques for Quantifying Defect Densities within Crystals; 4.5 The Complementarity of Techniques for Characterizing Defects; 4.6 Summary and Outlook; Acknowledgment; References; Chapter 5: "Enantiomeric Disorder" Pharmaceutically Oriented; 5.1 Introduction; 5.2 Introduction and Lexicon of Specific Terms Used among Chiral Molecules and Chiral Molecular Associations; 5.3 Restrictions in Symmetry Operations Inside Crystal Lattices with an Enantiomeric Excess Different from Zero 5.4 Impact of Chirality on Phase Diagrams and the Gibbs-Scott Phase Rule5.5 Competitions between Solid Solutions (Impact of Polymorphism on Solid Solutions) Application: Preferential Enrichment; 5.6 Disorder at Level 3 Multiepitaxy between Enantiomers; 5.7 Conclusion and Perspectives; Acknowledgments; References; Chapter 6: Conformational Disorder and Atropisomerism in Pharmaceutical Compounds; 6.1 Premise: Conformational Energy Barriers in Flexible Molecules; 6.2 Conformational Topology and Crystallization of Chain Molecules 6.3 Conformational Polymorphism and Crystallization of Flexible Molecules6.4 Conformational Flexibility of Ring Molecules: Carbohydrates; 6.5 Hindered Conformational Isomerism: Atropisomerism; 6.6 Conclusion; Acknowledgments; References; Chapter 7: Tautomerism in Drug Delivery; 7.1 Broadband Dielectric Spectroscopy as a Powerful Tool for Investigating the Tautomerization Process in Condensed Materials; 7.2 Tautomerization Kinetics of Supercooled Pharmaceuticals; Acknowledgment; References; Chapter 8: Disorders in Pharmaceutical Polymers; 8.1 Polymers Architectures - Structural Disorders 8.2 Structural States and Phases Transitions |
| Record Nr. | UNINA-9910136779403321 |
| Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Company KGaA, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Disordered pharmaceutical materials / / edited by Marc Descamps
| Disordered pharmaceutical materials / / edited by Marc Descamps |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Company KGaA, , [2016] |
| Descrizione fisica | 1 online resource (646 p.) |
| Soggetto topico |
Materials biomèdics
Biotecnologia farmacèutica Pharmaceutical biotechnology Biomedical materials |
| ISBN |
3-527-65269-8
3-527-65272-8 3-527-65271-X 9783527652693 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title Page; Copyright; Table of Contents; List of Contributors; Chapter 1: Some Facets of Molecular Disorder in Crystalline and Amorphous Pharmaceuticals; 1.1 The Crystal/Amorph Alternative; 1.2 Characteristics of the Disorder in Glass Formers; Acknowledgments; References; Chapter 2: Influence of Disorder on Dissolution; 2.1 Introduction; 2.2 Approaches to Enhance Solubility; 2.3 Measuring the Solubility Advantage of Amorphous Compounds; 2.4 Solid Dispersions; 2.5 Polymer Properties; 2.6 Drug-Polymer Interactions; 2.7 Polymer Concentration; 2.8 Other Formulation Components
2.9 Formulation Variables2.10 Reliable Measurement of Supersaturation; 2.11 Conclusion; References; Chapter 3: Crystal Imperfections in Molecular Crystals: Physical and Chemical Consequences; 3.1 Introduction; 3.2 General Aspects of Defects in Crystals; 3.3 Role of Imperfections in Reactivity and Stability - Chemistry in the Perfect and Imperfect Lattice; 3.4 Role in Physical Processes; 3.5 Concluding Remarks; References; Chapter 4: Observation and Characterization of Crystal Defects in Pharmaceutical Solids; 4.1 Introduction; 4.2 Techniques for Characterizing Defects within Crystals 4.3 Techniques for Characterizing Defects Emergent at Crystal Surfaces4.4 Techniques for Quantifying Defect Densities within Crystals; 4.5 The Complementarity of Techniques for Characterizing Defects; 4.6 Summary and Outlook; Acknowledgment; References; Chapter 5: "Enantiomeric Disorder" Pharmaceutically Oriented; 5.1 Introduction; 5.2 Introduction and Lexicon of Specific Terms Used among Chiral Molecules and Chiral Molecular Associations; 5.3 Restrictions in Symmetry Operations Inside Crystal Lattices with an Enantiomeric Excess Different from Zero 5.4 Impact of Chirality on Phase Diagrams and the Gibbs-Scott Phase Rule5.5 Competitions between Solid Solutions (Impact of Polymorphism on Solid Solutions) Application: Preferential Enrichment; 5.6 Disorder at Level 3 Multiepitaxy between Enantiomers; 5.7 Conclusion and Perspectives; Acknowledgments; References; Chapter 6: Conformational Disorder and Atropisomerism in Pharmaceutical Compounds; 6.1 Premise: Conformational Energy Barriers in Flexible Molecules; 6.2 Conformational Topology and Crystallization of Chain Molecules 6.3 Conformational Polymorphism and Crystallization of Flexible Molecules6.4 Conformational Flexibility of Ring Molecules: Carbohydrates; 6.5 Hindered Conformational Isomerism: Atropisomerism; 6.6 Conclusion; Acknowledgments; References; Chapter 7: Tautomerism in Drug Delivery; 7.1 Broadband Dielectric Spectroscopy as a Powerful Tool for Investigating the Tautomerization Process in Condensed Materials; 7.2 Tautomerization Kinetics of Supercooled Pharmaceuticals; Acknowledgment; References; Chapter 8: Disorders in Pharmaceutical Polymers; 8.1 Polymers Architectures - Structural Disorders 8.2 Structural States and Phases Transitions |
| Record Nr. | UNINA-9910830561803321 |
| Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Company KGaA, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmaceutical Nanobiotechnology for Targeted Therapy / / edited by Hamed Barabadi, Ebrahim Mostafavi, Muthupandian Saravanan
| Pharmaceutical Nanobiotechnology for Targeted Therapy / / edited by Hamed Barabadi, Ebrahim Mostafavi, Muthupandian Saravanan |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (641 pages) |
| Disciplina | 615.19 |
| Collana | Nanotechnology in the Life Sciences |
| Soggetto topico |
Biotechnology
Biology - Technique Molecular biology Nanotechnology Biological Techniques Molecular Biology Biotecnologia farmacèutica Ultraestructura (Biologia) Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-12658-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Chapter. 1. Outer Membrane Vesicles (OMVs) as a Platform for Vaccination and Targeted Drug Delivery -- Chapter. 2. CRISPR/Cas9 Nano-Delivery Approaches for Targeted Gene Therapy -- Chapter. 3. Lipoplexes and Polyplexes for Targeted Gene Delivery -- Chapter. 4. Aptamer-Based Targeted Drug Delivery Systems -- Chapter. 5. Artificial Exosomes as Targeted Drug Delivery Systems -- Chapter. 6. Nanoarchaeosomes in drug delivery -- Chapter. 7. Bioengineered Metallic Nanomaterials for Nanoscale Drug Delivery Systems -- Chapter. 8. Nanobody-Based Delivery Systems for Diagnosis and Therapeutic Applications -- Chapter. 9. Phytosomes Used for Herbal Drug Delivery -- Chapter. 10. Porphysomes and porphyrin-based nanomaterials for drug delivery system -- Chapter. 11. Ethosomes for Dermal and Transdermal Drug Delivery Systems -- Chapter. 12. Liposomes and Niosomes for Targeted Drugs and Gene Delivery Systems -- Chapter. 13. Dendrimers as Targeted Systems for Selective Gene and Drug delivery -- Chapter. 14. Polymersomes for Targeted Drug and Gene Delivery Systems -- Chapter. 15. Quantum-Dot-Based Nanomaterials for Diagnostic and Therapeutic applications -- Chapter. 16. Carbon-based Nanomaterials for Targeted Drug and Gene Delivery Systems -- Chapter. 17. Hybrid Multifunctional Nanomaterials for Diagnostic and Therapeutic Applications -- Chapter. 18. Polymeric Micelles for Targeted Drug Delivery Systems -- Chapter. 19. Polymeric Nanoparticles for Targeted Drug and Gene Delivery Systems -- Chapter. 20. Magnetic Nanoparticles for Diagnostic and Therapeutic Applications. |
| Record Nr. | UNINA-9910619279003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
